CIP
Cornerstone Investment Partners Portfolio holdings
AUM
$2.38B
1-Year Est. Return
32.49%
This Fund
S&P 500
1 Year Est. Return
+32.49%
AUM
$2.38B
AUM Growth
-$199M
(-7.7%)
Holding
333
Top Buys
| 1 | +$45.6M | |
| 2 | +$22M | |
| 3 | +$6.85M | |
| 4 |
JPMorgan Chase
JPM
|
+$5.79M |
| 5 |
Visa
V
|
+$4.96M |
Top Sells
| 1 | +$74.4M | |
| 2 | +$22M | |
| 3 | +$20.3M | |
| 4 |
Broadcom
AVGO
|
+$17.6M |
| 5 |
Elevance Health
ELV
|
+$8.04M |
Sector Composition
| 1 | Technology | 27.09% |
| 2 | Financials | 20.33% |
| 3 | Healthcare | 16.04% |
| 4 | Communication Services | 12.76% |
| 5 | Consumer Discretionary | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Curtiss-Wright
CW
$26.6B
| – | – |
-583
|
|
||
327
CryoPort
CYRX
$793M
| – | – |
-18,317
|
|
||
328
National Storage Affiliates Trust
NSA
$3.23B
| – | – |
-8,888
|
|
||
329
Navigator Holdings
NVGS
$1.37B
| – | – |
-14,720
|
|
||
330
Organogenesis Holdings
ORGO
$288M
| – | – |
-33,627
|
|
||
331
Protagonist Therapeutics
PTGX
$6B
| – | – |
-4,634
|
|
||
|
RERE
332
ATRenew
RERE
$1.01B
| – | – |
-34,795
|
|
||
|
NAGE
333
Niagen Bioscience
NAGE
$282M
| – | – |
-24,875
|
|